278 related articles for article (PubMed ID: 33491744)
1. Polycomb repressor complex 2 function in breast cancer (Review).
Martin CJ; Moorehead RA
Int J Oncol; 2020 Nov; 57(5):1085-1094. PubMed ID: 33491744
[TBL] [Abstract][Full Text] [Related]
2. Inner workings and regulatory inputs that control Polycomb repressive complex 2.
O'Meara MM; Simon JA
Chromosoma; 2012 Jun; 121(3):221-34. PubMed ID: 22349693
[TBL] [Abstract][Full Text] [Related]
3. Interactions between JARID2 and noncoding RNAs regulate PRC2 recruitment to chromatin.
Kaneko S; Bonasio R; Saldaña-Meyer R; Yoshida T; Son J; Nishino K; Umezawa A; Reinberg D
Mol Cell; 2014 Jan; 53(2):290-300. PubMed ID: 24374312
[TBL] [Abstract][Full Text] [Related]
4. EZH2 methyltransferase and H3K27 methylation in breast cancer.
Yoo KH; Hennighausen L
Int J Biol Sci; 2012; 8(1):59-65. PubMed ID: 22211105
[TBL] [Abstract][Full Text] [Related]
5. Polycomb Gene Silencing Mechanisms: PRC2 Chromatin Targeting, H3K27me3 'Readout', and Phase Separation-Based Compaction.
Guo Y; Zhao S; Wang GG
Trends Genet; 2021 Jun; 37(6):547-565. PubMed ID: 33494958
[TBL] [Abstract][Full Text] [Related]
6. Tissue-Specific Tumour Suppressor and Oncogenic Activities of the Polycomb-like Protein MTF2.
Ngubo M; Moradi F; Ito CY; Stanford WL
Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895228
[TBL] [Abstract][Full Text] [Related]
7. Repression of E-cadherin by the polycomb group protein EZH2 in cancer.
Cao Q; Yu J; Dhanasekaran SM; Kim JH; Mani RS; Tomlins SA; Mehra R; Laxman B; Cao X; Yu J; Kleer CG; Varambally S; Chinnaiyan AM
Oncogene; 2008 Dec; 27(58):7274-84. PubMed ID: 18806826
[TBL] [Abstract][Full Text] [Related]
8. RNA helicase DEAD box protein 5 regulates Polycomb repressive complex 2/Hox transcript antisense intergenic RNA function in hepatitis B virus infection and hepatocarcinogenesis.
Zhang H; Xing Z; Mani SK; Bancel B; Durantel D; Zoulim F; Tran EJ; Merle P; Andrisani O
Hepatology; 2016 Oct; 64(4):1033-48. PubMed ID: 27338022
[TBL] [Abstract][Full Text] [Related]
9. Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer.
Ren G; Baritaki S; Marathe H; Feng J; Park S; Beach S; Bazeley PS; Beshir AB; Fenteany G; Mehra R; Daignault S; Al-Mulla F; Keller E; Bonavida B; de la Serna I; Yeung KC
Cancer Res; 2012 Jun; 72(12):3091-104. PubMed ID: 22505648
[TBL] [Abstract][Full Text] [Related]
10. Structure, mechanism, and regulation of polycomb-repressive complex 2.
Moritz LE; Trievel RC
J Biol Chem; 2018 Sep; 293(36):13805-13814. PubMed ID: 28912274
[TBL] [Abstract][Full Text] [Related]
11. Recent Structural Insights into Polycomb Repressive Complex 2 Regulation and Substrate Binding.
Kasinath V; Poepsel S; Nogales E
Biochemistry; 2019 Feb; 58(5):346-354. PubMed ID: 30451485
[TBL] [Abstract][Full Text] [Related]
12. The recruitment of chromatin modifiers by long noncoding RNAs: lessons from PRC2.
Davidovich C; Cech TR
RNA; 2015 Dec; 21(12):2007-22. PubMed ID: 26574518
[TBL] [Abstract][Full Text] [Related]
13. Small Molecule Approaches for Targeting the Polycomb Repressive Complex 2 (PRC2) in Cancer.
Martin MC; Zeng G; Yu J; Schiltz GE
J Med Chem; 2020 Dec; 63(24):15344-15370. PubMed ID: 33283516
[TBL] [Abstract][Full Text] [Related]
14. 16-hydroxycleroda-3,13-dien-15,16-olide regulates the expression of histone-modifying enzymes PRC2 complex and induces apoptosis in CML K562 cells.
Lin YH; Lee CC; Chang FR; Chang WH; Wu YC; Chang JG
Life Sci; 2011 Dec; 89(23-24):886-95. PubMed ID: 21983300
[TBL] [Abstract][Full Text] [Related]
15. The polycomb repressive complex 2 is a potential target of SUMO modifications.
Riising EM; Boggio R; Chiocca S; Helin K; Pasini D
PLoS One; 2008 Jul; 3(7):e2704. PubMed ID: 18628979
[TBL] [Abstract][Full Text] [Related]
16. Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes.
Holm K; Grabau D; Lövgren K; Aradottir S; Gruvberger-Saal S; Howlin J; Saal LH; Ethier SP; Bendahl PO; Stål O; Malmström P; Fernö M; Rydén L; Hegardt C; Borg Å; Ringnér M
Mol Oncol; 2012 Oct; 6(5):494-506. PubMed ID: 22766277
[TBL] [Abstract][Full Text] [Related]
17. LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1.
Sun M; Nie F; Wang Y; Zhang Z; Hou J; He D; Xie M; Xu L; De W; Wang Z; Wang J
Cancer Res; 2016 Nov; 76(21):6299-6310. PubMed ID: 27651312
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA.
Kaneko S; Li G; Son J; Xu CF; Margueron R; Neubert TA; Reinberg D
Genes Dev; 2010 Dec; 24(23):2615-20. PubMed ID: 21123648
[TBL] [Abstract][Full Text] [Related]
19. Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells.
Li H; Cai Q; Godwin AK; Zhang R
Mol Cancer Res; 2010 Dec; 8(12):1610-8. PubMed ID: 21115743
[TBL] [Abstract][Full Text] [Related]
20. NBAT1 suppresses breast cancer metastasis by regulating DKK1 via PRC2.
Hu P; Chu J; Wu Y; Sun L; Lv X; Zhu Y; Li J; Guo Q; Gong C; Liu B; Su S
Oncotarget; 2015 Oct; 6(32):32410-25. PubMed ID: 26378045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
